Valneva SE (INRLF)
OTCMKTS · Delayed Price · Currency is USD
4.750
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $837.43 million as of February 12, 2026. Its market cap has increased by 87.06% in one year.
Market Cap
837.43M
Enterprise Value
899.58M
Revenue
211.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.75
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 133.86M to 837.43M, an increase of 525.59%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 837.43M | 11.04% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |